Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS

Label-free fluorescence lifetime analysis for the screening of nanoencapsulated drugs

Objective

Nanomedicine has the potential to revolutionize healthcare by enabling targeted drug delivery, reducing side effects, and improving treatment efficacy. However, the field faces a critical bottleneck: the lack of efficient, non-invasive analytical tools to assess drug encapsulation, stability, and release dynamics in nanoformulations. Current techniques rely on destructive, time-consuming methods, limiting their applicability in formulation development and quality control.
enLIGHT introduces a breakthrough approach—a patented, label-free fluorescence lifetime-based screening technology that provides real-time, quantitative insights into the physical state of encapsulated drugs. By leveraging exploitation of the intrinsic luminescence of drugs and a phasor-based, fit-free and purely graphical analysis, enLIGHT eliminates the need for fluorescent labeling or complex sample preparation, offering a rapid, cost-effective, and non-destructive alternative to traditional characterization techniques.
Validated in laboratory settings, enLIGHT has already revealed unexpected drug behaviors in FDA-approved nanomedicines, demonstrating its ability to uncover hidden formulation instabilities.
This Proof of Concept project aims to move enLIGHT from a complex lab setup to a compact, user-friendly device for pharmaceutical and research laboratories. By refining the prototype and validating its performance across diverse nanoformulations, the project will establish enLIGHT as an indispensable tool in nanomedicine analytics.
With its potential to enhance drug development pipelines, reduce formulation failures, and streamline regulatory approval processes, enLIGHT represents a transformative innovation for the pharmaceutical industry—ensuring more stable, effective, and safer nanomedicines for the future.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.

You need to log in or register to use this function

Programme(s)

Multi-annual funding programmes that define the EU’s priorities for research and innovation.

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

HORIZON-ERC-POC - HORIZON ERC Proof of Concept Grants

See all projects funded under this funding scheme

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

(opens in new window) ERC-2025-POC

See all projects funded under this call

Host institution

SCUOLA NORMALE SUPERIORE
Net EU contribution

Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.

€ 115 000,00
Address
PIAZZA DEI CAVALIERI 7
56126 PISA
Italy

See on map

Region
Centro (IT) Toscana Pisa
Activity type
Higher or Secondary Education Establishments
Links
Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

No data

Beneficiaries (2)

My booklet 0 0